COSM · Cosmos Health Inc. · Executive Compensation
$0.30
+0.01 (+4.93%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the date of this filing.”View the 10-Q filed Aug 18, 2026
Market Cap
$29.17M
Shares
100.63M
Volume · Nov 6
1.05M
Avg daily vol (3M)
3.01M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Theodoros C. Karkantzos | director | Appointed | 2026-07-16 |
| Dr. Anastasios Aslidis | director | Appointed | 2026-07-16 |
| Suhel Bhutawala | director | Appointed | 2026-07-16 |
| John J. Hoidas | director | Appointed | 2026-07-16 |
| Demetrios G. Demetriades | director | Appointed | 2026-07-16 |
| Grigorios Siokas | director | Appointed | 2026-07-16 |
| Theodoros C. Karkantzos | member of the Board | Appointed | 2025-10-06 |
| Theodoros C. Karkantzos | director | Appointed | 2025-10-01 |
| Suhel Bhutawala | director | Appointed | 2025-10-01 |
| John J. Hoidas | director | Appointed | 2025-10-01 |
| Dr. Anastasios Aslidis | director | Appointed | 2025-10-01 |
| Demetrios G. Demetriades | director | Appointed | 2025-10-01 |
| Grigorios Siokas | director | Appointed | 2025-10-01 |
| Pavlos Ignatiades | Chief Communications Officer | Resigned | 2023-09-22 |
| Nikos Bardakis | Chief Operating Officer | Appointed | 2023-02-07 |
Leadership
- Georgios Terzis CFO
- Nikos Bardakis COO
- Pavlos Ignatiades COO
- Demetrios G. Demetriades Board Member
- Dr. Anastasios Aslidis Board Member
- Dr. Manfred Ziegler Board Member
- Grigorios Siokas Board Member
- John J. Hoidas Board Member
- Peter Goldstein Board Member
- Suhel Bhutawala Board Member
- Theodoros C. Karkantzos Board Member
Key facts
CIK
1474167
CUSIP
221413305
13F (30d)
13 filings
9 filers
Visit website
Investor relations